Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYK2 | P29597 | 18/20 | 0.81 |
| ▸ | STAT3 | P40763 | 1/20 | 0.80 |
| ▸ | JAK1 | P23458 | 3/20 | 0.78 |
| ▸ | JAK2 | O60674 | 1/20 | 0.78 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.78 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.78 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22342946 | 1.00 | TYK2 (0.81) | TYK2STAT3JAK1JAK2CYP3A4 | |
| SCHEMBL20687805 | 0.97 | TYK2 (0.85) | TYK2STAT3JAK1JAK2CYP3A4 | |
| SCHEMBL29746681 | 0.97 | TYK2 (0.85) | TYK2STAT3JAK1JAK2CYP3A4 | |
| SCHEMBL20697438 | 0.90 | TYK2 (1.00) | TYK2STAT3JAK1JAK2CYP3A4 | |
| SCHEMBL21947010 | 0.89 | TYK2 (1.00) | TYK2STAT3JAK1JAK2CYP3A4 | |
| SCHEMBL20688569 | 0.89 | TYK2 (1.00) | TYK2STAT3JAK1JAK2CYP3A4 | |
| SCHEMBL20697531 | 0.89 | TYK2 (0.78) | TYK2JAK1 | |
| SCHEMBL21947000 | 0.89 | TYK2 (1.00) | TYK2STAT3JAK1JAK2CYP3A4 | |
| SCHEMBL21960502 | 0.89 | TYK2 (1.00) | TYK2STAT3JAK1JAK2CYP3A4 | |
| SCHEMBL20688659 | 0.89 | TYK2 (1.00) | TYK2STAT3JAK1JAK2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220135567-A1 | TYK2 PSEUDOKINASE LIGANDS | VENTYX BIOSCIENCES, INC. | 2022-05-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220135567-A1 | TYK2 PSEUDOKINASE LIGANDS | TYK2, JAK2, PTK2B | TYK2 1/4885STAT3 76/4885JAK1 6/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.